Entecavir Does Not Eliminate HCC Risk in Hepatitis B PatientsEntecavir Does Not Eliminate HCC Risk in Hepatitis B Patients

Patients taking entecavir for chronic hepatitis B are still at risk for hepatocellular carcinoma (HCC), a recent study suggests. Reuters Health Information
Source: Medscape Gastroenterology Headlines - Category: Gastroenterology Tags: Hematology-Oncology News Source Type: news